Profitability Ratios
| Ratio |
Value |
| GP Margin |
17.9% |
| EBIT Margin |
10.7% |
| EBITDA Margin |
13.5% |
| Operating Margin |
9.6% |
| Pretax Margin |
8.7% |
| Cont. Ops Margin |
5.8% |
| Net Margin |
5.6% |
| Bottom Line Margin |
5.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
2.02 |
| Quick Ratio |
1.51 |
| Solvency Ratio |
0.142 |
| Cash Ratio |
0.21 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
15.79 |
| Forward PEG |
15.79 |
| Price/Book |
2.80 |
| Price/Sales |
1.42 |
| Price/FCF |
33.00 |
| Price/Op Cash Flow |
20.05 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2809 |
| Debt/Equity |
0.6166 |
| Debt/Capital |
0.3814 |
| Long-Term Debt/Capital |
0.2930 |
| Financial Leverage |
2.20 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
4.43 |
| Operating Cash Flow Ratio |
0.351 |
| Operating Cash Flow/Sales |
7.1% |
| Free Cash Flow/Operating Cash Flow |
60.8% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
5.26 |
| Interest Coverage |
4.7756 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
0.23 |
| Capital Expenditure Coverage |
2.55 |
| Dividend + Capital Expenditure Coverage |
2.26 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
6.2995% |
| Dividend Yield |
0.2507% |
| Dividend Yield % |
0.2507% |
| Dividend Per Share |
0.0402 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
11.32 |
| EPS |
0.638 |
| Debt/Share |
3.7547 |
| Cash/Share |
0.49 |
| Book Value/Share |
5.85 |
| Tangible BV/Share |
3.43 |
| Equity/Share |
5.72 |
| Operating Cash Flow/Share |
0.799 |
| Capital Expenditure/Share |
0.314 |
| FCF/Share |
0.486 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.646 |
| Earnings Before Tax/EBIT |
0.909 |
| Price/Fair Value |
2.80 |
| Debt/Market Cap |
0.1479 |
| Effective Tax Rate |
33.8% |
| Enterprise Value Multiple |
12.47 |
CLB - Core Laboratories N.V.